Trending News
News
News
Timing is Everything in Phage Therapy
Mathematical model sheds light on the timing of key, intracellular events.
News
U.S. FDA Accepts Licence For Biosimilar Trastuzumab
Mylan (UK) and Biocon's (IND) license application for biosimilar to branded trastuzumab for the treatment of HER2-positive breast cancers receives FDA acceptance.
News
AGC Acquires CMC Biologics
AGC Asahi Glass - a subsidiary of AGC Group - acquires CMC Biologics for $516m.
News
Amgen And Immatics Collaborate To Develop Cancer Immunotherapies
Amgen and Immatics announce collaboration and exclusive license agreement to develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancers.
News
Genedata, Crescendo Biologics Partner
Crescendo implements Genedata Biologics as backbone workflow system.
News
Bacterial Pac Man Molecule Snaps at Sugar
Scientists at the University of Bonn have analyzed the dynamics of a bacterial molecule, demonstrating that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used.
News
Tumor Suppressor LATS Key Driver of Breast Cancer
Comprehensive study finds how the enzyme LATS plays a key role in the development and treatment of breast cancer.
News
Pfizer, Scripps Partner on DNA-Encoded Library Tech
Collaboration focuses on the creation of next-generation DELS, a potentially revolutionary technology for early stage drug discovery.
News
KemPharm Post Positive Results From Phase 1 Trial
KemPharm reports positive results from its Phase 1 intranasal pharmacokinetic trial of KP511, an investigational prodrug of hydromorphone for the treatment of pain.
News
Spinning spider silk is now possible
A team of researchers from the Swedish University of Agricultural Sciences and Karolinska Institutet have developed a method for making artificial spider silk. The reported that they can produce kilometer long threads that for the first time resemble real spider silk.
Advertisement